RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 PRESERVE Trial: Patients with Moderately Active RA Achieve and Maintain Low Disease Activity and Remission with Anti-TNF Therapy More Successfully than Those with High Disease Activity
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 13
SP 18
OP 19
DO 10.1177/155989771113012
UL http://mdc.sagepub.com/content/11/13/18.abstract
AB Data from the Randomized, Double-Blind Study Comparing the Safety & Efficacy of Once-Weekly Etanercept 50 mg, Etanercept 25 mg, & Placebo in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis [PRESERVE; NCT00565409] show that patients with moderately active rheumatoid arthritis (RA) achieve and maintain low disease activity and remission with anti-tumor necrosis factor therapy more successfully than those with high RA activity [Keystone E et al. J Rheumatol 2009].